```html

Jaundice Induced by Gallstones

Overview

Jaundice is the yellow‑coloring of the skin, the whites of the eyes (sclerae), and mucous membranes that occurs when the blood level of bilirubin rises above normal. When gallstones block the bile ducts, bile cannot flow from the liver to the intestine, causing bilirubin to build up and leading to jaundice. This condition is often referred to as **obstructive jaundice** or **cholestatic jaundice** caused by gallstones.

Who it affects: Gallstone‑related jaundice most commonly occurs in adults over 40 years of age, especially women, who are up to three times more likely to develop gallstones than men. However, it can affect anyone with risk factors for stone formation, including children with certain metabolic disorders.

Prevalence: In the United States, about 10–15 % of adults develop gallstones, and 10–20 % of those will experience a complication such as jaundice each year.<sup>[1] Mayo Clinic</sup> Worldwide, the prevalence of gallstones ranges from 5 % in Africa to 25 % in Europe and North America.<sup>[2] WHO</sup>

Symptoms

The symptom profile can vary from mild to severe depending on how completely the duct is blocked and whether infection is present.

General symptoms of jaundice

• Yellow skin and eyes – the most recognizable sign; may start on the face and spread down the torso.
• Itching (pruritus) – caused by bile salts accumulating under the skin.
• Dark urine – bilirubin is excreted by the kidneys, turning urine a tea‑color.
• Pale stools – lack of stercobilin (a bile pigment) makes stools appear clay‑colored.

Symptoms specific to gallstone obstruction

• Right‑upper‑quadrant (RUQ) abdominal pain – often sudden, severe, and may radiate to the back or shoulder.
• Colicky pain after fatty meals – gallbladder contraction against an obstructed duct.
• Nausea and vomiting – especially if the stone is moving.
• Fever or chills – may indicate secondary infection (cholangitis).
• Loss of appetite and weight loss – due to discomfort and malabsorption.

Red‑flag symptoms that suggest an emergency

• High fever (>38.5 °C / 101 °F) with chills
• Severe, constant RUQ pain lasting >2 hours
• Rapid mental status change or confusion (possible hepatic encephalopathy)
• Rapidly worsening jaundice or swelling of the abdomen (ascites)

Causes and Risk Factors

Gallstones form when the balance of cholesterol, bilirubin, and bile salts in the gallbladder is disturbed. When a stone migrates into the common bile duct (CBD) or the cystic duct, it creates a blockage that prevents bile from draining, leading to bilirubin accumulation.

Primary causes

• Cholesterol stones – the most common type (≈80 %). Over‑supersaturation of cholesterol in bile.
• Pigment stones – formed from excess bilirubin, more common in hemolytic disorders, cirrhosis, or infections.
• Mixed stones – contain both cholesterol and calcium bilirubinate.

Risk factors

• Female sex (estrogen increases cholesterol secretion)
• Age > 40 years
• Obesity (BMI > 30 kg/m²)
• Rapid weight loss or very low‑calorie diets
• Pregnancy
• Diabetes mellitus
• Family history of gallstones
• Certain ethnicities (Native American, Hispanic, Scandinavian)
• Chronic hemolysis (sickle cell disease, thalassemia)
• Use of estrogen‑containing medications (birth control pills, hormone replacement therapy)

Diagnosis

Diagnosing jaundice caused by gallstones involves confirming both the presence of jaundice (elevated bilirubin) and the obstructive source.

Laboratory tests

• Serum bilirubin – total > 2.5 mg/dL usually indicates clinically visible jaundice.
• Direct (conjugated) bilirubin – elevated in obstructive jaundice.
• Liver function panel – alkaline phosphatase (ALP) and gamma‑glutamyl transferase (GGT) rise markedly with obstruction; transaminases (ALT/AST) may be mildly elevated.
• Complete blood count (CBC) – to detect infection (elevated white cells) or anemia from hemolysis.
• Serum lipase/amylase – to rule out pancreatitis, which can coexist.

Imaging studies

• Abdominal ultrasound – first‑line; detects gallstones, biliary duct dilatation, and gallbladder wall thickening.
• Magnetic resonance cholangiopancreatography (MRCP) – non‑invasive MRI that visualizes the entire biliary tree; highly sensitive for stones in the CBD.
• Endoscopic retrograde cholangiopancreatography (ERCP) – diagnostic and therapeutic; allows direct removal of stones but carries risk of pancreatitis.
• CT scan – useful if complications such as perforation or abscess are suspected.

Other assessments

• Hepatobiliary iminodiacetic acid (HIDA) scan – evaluates bile flow when ultrasound is inconclusive.
• Stool color test – confirms pale stools, supporting cholestasis.

Treatment Options

Therapeutic goals are to relieve the obstruction, treat any infection, and prevent recurrence.

Acute management

• Hospital admission – indicated for most patients with obstructive jaundice, especially if fever, severe pain, or lab abnormalities are present.
• IV fluids – maintain hydration and renal perfusion.
• Pain control – IV opioids (e.g., hydromorphone) or non‑opioid analgesics; avoid NSAIDs in severe liver dysfunction.
• Antibiotics – start broad‑spectrum (e.g., ceftriaxone + metronidazole) if cholangitis is suspected; tailor later to cultures.
• Ursodeoxycholic acid (UDCA) – may be used to improve bile flow in mild obstruction, but not a substitute for stone removal.

Definitive stone removal

1. Endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy – first‑line for CBD stones; a balloon or basket extracts the stone.
2. Laparoscopic cholecystectomy – removal of the gallbladder; performed during the same admission in many centers after ERCP clearance.
3. Percutaneous transhepatic biliary drainage (PTBD) – used when ERCP is not possible (e.g., altered anatomy).
4. Open surgical exploration – reserved for massive stones or failed minimally invasive attempts.

Post‑procedure care

• Monitor liver enzymes and bilirubin for 24–48 hours.
• Continue antibiotics if infection was present.
• Gradual re‑introduction of a low‑fat diet, progressing to normal as tolerated.

Lifestyle and medical adjuncts

• Weight management – lose 5–10 % body weight if overweight; avoid rapid weight‑loss diets.
• Dietary modifications – limit saturated fats, increase fiber, stay hydrated.
• Regular physical activity – at least 150 minutes of moderate exercise per week.
• Control of diabetes and lipid levels – using medications as prescribed.

Living with Jaundice Induced by Gallstones

Even after successful stone removal, patients may experience lingering fatigue or itching as the liver recovers.

• Skin care – use gentle, fragrance‑free moisturizers; cool compresses can soothe itching.
• Hydration – aim for 2–3 L of water daily to help the liver flush bilirubin.
• Nutrition – prioritize lean protein (fish, poultry), whole grains, and plenty of fruits/vegetables. Small, frequent meals may be easier on the digestive system.
• Medication adherence – finish any prescribed antibiotics or UDCA courses, even if you feel better.
• Follow‑up appointments – typically at 4–6 weeks post‑procedure, then annually, to monitor liver enzymes and assess for stone recurrence.
• Support resources – patient education groups, dietitian counseling, and mental‑health services can help cope with lifestyle shifts.

Prevention

Because most gallstones develop long before they cause jaundice, primary prevention focuses on reducing stone formation.

1. Maintain a healthy weight – BMI 18.5–24.9. Gradual weight loss (½–1 lb per week) is safest.
2. Eat a balanced diet – high‑fiber (≥25 g/day), low‑saturated‑fat, and include healthy fats (omega‑3).
3. Stay active – regular aerobic activity lowers cholesterol saturation in bile.
4. Limit rapid‑weight‑loss regimens – very low‑calorie diets (<800 kcal/day) increase cholesterol stone risk.
5. Consider prophylactic UDCA – for high‑risk patients (e.g., those with known small stones or after bariatric surgery) under physician guidance.<sup>[3] Cleveland Clinic</sup>
6. Manage medical conditions – keep diabetes, hyperlipidemia, and hemolytic diseases under control.

Complications

If the obstruction is not promptly relieved, several serious complications can arise:

• Acute cholangitis – bacterial infection of the biliary tree; can progress to sepsis.
• Pancreatitis – gallstone migration into the pancreatic duct.
• Secondary biliary cirrhosis – chronic cholestasis leading to fibrosis and liver failure.
• Portal hypertension – due to liver scarring.
• Gallbladder cancer – long‑standing gallstones increase risk, especially in porcelain gallbladder.
• Kidney injury – high bilirubin can precipitate pigment nephropathy.

When to Seek Emergency Care

---

References

1. Mayo Clinic. “Gallstones.” Updated 2023. https://www.mayoclinic.org
2. World Health Organization. “Global health estimates on gallstone disease.” 2022.
3. Cleveland Clinic. “Ursodeoxycholic Acid (UDCA) for Gallstone Prevention.” 2021.
4. American College of Gastroenterology. “Guidelines for the Diagnosis and Management of Biliary Tract Disease.” 2020.
5. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Gallstones.” 2023.

```